Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kumarasamy, Nagalingeswaran"" wg kryterium: Autor


Tytuł:
The changing characteristics of a cohort of children and adolescents living with HIV at antiretroviral therapy initiation in Asia.
Autorzy:
Sornillo JB; Department of Epidemiology and Biostatistics, Research Institute for Tropical Medicine, Manila, Philippines.
Ditangco R; Medical Department, Research Institute for Tropical Medicine, Manila, Philippines.
Kinikar A; BJ Medical College and Sassoon General Hospital, Pune, India.
Wati DK; Department of Pediatrics, Sanglah Hospital, Udayana University, Bali, Indonesia.
Du QT; Infectious Diseases Department, Children's Hospital 1, Ho Chi Minh City, Vietnam.
Nguyen DQ; Infectious Diseases Department, Children's Hospital 2, Ho Chi Minh City, Vietnam.
Khol V; National Center for HIV/AIDS, Dermatology and STD, Phnom Penh, Cambodia.
Nguyen LV; Infectious Diseases Department, National Hospital of Pediatrics, Hanoi, Vietnam.
Puthanakit T; Department of Pediatrics, Faculty of Medicine and Research Unit in Pediatric and Infectious Diseases, Chulalongkorn University, Bangkok, Thailand.
Ounchanum P; Department of Pediatrics, Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Kurniati N; Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo, Jakarta, Indonesia.
Chokephaibulkit K; Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Jamal Mohamed TA; Pediatric Institute, Women and Children Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
Sudjaritruk T; Department of Pediatrics, Faculty of Medicine, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Fong SM; Department of Pediatrics, Hospital Likas, Kota Kinabalu, Malaysia.
Kumarasamy N; VHS-Infectious Diseases Medical Centre, Chennai, India.
Kosalaraksa P; Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Nallusamy RA; Department of Pediatrics, Penang Hospital, Penang, Malaysia.
Nik Yusoff NK; Department of Pediatrics, Hospital Raja Perempuan Zainab II, Kota Bharu, Malaysia.
Sohn AH; TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand.
Kariminia A; The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Pokaż więcej
Corporate Authors:
TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific
Źródło:
PloS one [PLoS One] 2023 Sep 14; Vol. 18 (9), pp. e0291523. Date of Electronic Publication: 2023 Sep 14 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Opportunistic Infections*
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Male ; Ambulatory Care ; Anti-Retroviral Agents/therapeutic use ; Asia/epidemiology
Czasopismo naukowe
Tytuł:
Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.
Autorzy:
Ross J; TREAT Asia, amfAR, The Foundation for AIDS Research, Bangkok, Thailand.
Rupasinghe D; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Avihingsanon A; HIV-NAT/ Thai Red Cross AIDS Research Centre and Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Lee MP; Queen Elizabeth Hospital, Hong Kong SAR, China.
Pujari S; Institute of Infectious Diseases, Pune, India.
Sharp G; National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America.
Kumarasamy N; CART CRS, Voluntary Health Services, Chennai, India.
Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Khol V; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Agus Somia IK; Faculty of Medicine, Prof. Dr. I.G.N.G. Ngoerah Hospital, Udayana University, Bali, Indonesia.
Pham TN; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Kiertiburanakul S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Duy Do C; Bach Mai Hospital, Hanoi, Vietnam.
Sohn AH; TREAT Asia, amfAR, The Foundation for AIDS Research, Bangkok, Thailand.
Jiamsakul A; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Pokaż więcej
Corporate Authors:
TAHOD-LITE study group of IeDEA Asia‐Pacific
Źródło:
PloS one [PLoS One] 2023 Jun 28; Vol. 18 (6), pp. e0287909. Date of Electronic Publication: 2023 Jun 28 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Coinfection*/drug therapy
Hepatitis C*/complications
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Adult ; Humans ; Adolescent ; Hepacivirus/genetics ; Thailand ; RNA, Viral ; Antiviral Agents/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Differential Expression of miRNA-192 is a Potential Biomarker for HIV Associated Immune Recovery Uveitis.
Autorzy:
Duraikkannu D; L&T Department of Ocular Pathology, Vision Research Foundation, Chennai, India.; Centre for Biotechnology, Anna University, Chennai, India.
Akbar AB; L&T Department of Ocular Pathology, Vision Research Foundation, Chennai, India.
Sudharshan S; Department of Uveitis, Medical Research Foundation, Sankara Nethralaya, Chennai, India.
Poongulali S; Infectious Diseases Medical Center, The Voluntary Health Services, Chennai, India.
Kumarasamy N; Infectious Diseases Medical Center, The Voluntary Health Services, Chennai, India.
Jayavelu T; Centre for Biotechnology, Anna University, Chennai, India.
Chatterjee N; L&T Department of Ocular Pathology, Vision Research Foundation, Chennai, India.
Pokaż więcej
Źródło:
Ocular immunology and inflammation [Ocul Immunol Inflamm] 2023 Apr; Vol. 31 (3), pp. 566-575. Date of Electronic Publication: 2022 Aug 10.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
MicroRNAs*/genetics
MicroRNAs*/metabolism
Uveitis*/diagnosis
Uveitis*/genetics
Humans ; Biomarkers ; Eye
Czasopismo naukowe
Tytuł:
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific region.
Autorzy:
Khuon D; Department of Epidemiology, University of California, Los Angeles, Los Angeles, California, USA.; Department of Public Health, University of Health Sciences, Phnom Penh, Cambodia.
Rupasinghe D; Biostatistics Department, The Kirby Institute, UNSW Sydney, Kensington, Australia.
Saphonn V; Department of Public Health, University of Health Sciences, Phnom Penh, Cambodia.
Kwong TS; Infectious Disease Department, Queen Elizabeth Hospital, Hong Kong, China.
Widhani A; Internal Medicine Department, Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Chaiwarith R; Internal Medicine Department, Chiang Mai University - Research Institute for Health Sciences, Chiang Mai, Thailand.
Ly PS; National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia.
Do CD; Infectious Diseases Department, Bach Mai Hospital, Hanoi, Vietnam.
Avihingsanon A; HIV-NAT/ Thai Red Cross AIDS Research Centre and Tuberculosis research unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Khusuwan S; Medicine Department, Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Merati TP; Internal Medicine Department, Faculty of Medicine Udayana University and Sanglah Hospital, Bali, Indonesia.
Van Nguyen K; Department of Infectious Diseases Epidemiology, National Hospital for Tropical Diseases, Hanoi, Vietnam.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
Chan YJ; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Azwa I; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Ng OT; Tan Tock Seng Hospital, National Centre for Infectious Diseases, Singapore.
Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Tanuma J; AIDS Medical Information Department, National Center for Global Health and Medicine, Tokyo, Japan.
Pujari S; Institute of Infectious Diseases, Pune, India.
Ditangco R; Department of Internal Medicine, Research Institute for Tropical Medicine, Muntinlupa, Philippines.
Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Gani Y; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
Sangle S; Department of Medicine, BJ Government Medical College and Sassoon General Hospitals, Pune, India.
Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Gorbach PM; Department of Epidemiology, University of California, Los Angeles, Los Angeles, California, USA.
Jiamsakul A; Biostatistics Department, The Kirby Institute, UNSW Sydney, Kensington, Australia.
Pokaż więcej
Corporate Authors:
IeDEA Asia-Pacific
Źródło:
HIV medicine [HIV Med] 2023 Feb; Vol. 24 (2), pp. 139-152. Date of Electronic Publication: 2022 Jun 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Overweight*/complications
Overweight*/epidemiology
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Humans ; Male ; Adult ; Female ; Blood Glucose ; Body Mass Index ; Thinness/complications ; Longitudinal Studies ; Risk Factors ; Obesity/complications ; Obesity/epidemiology ; Fasting
Czasopismo naukowe
Tytuł:
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance.
Autorzy:
Salata RA; Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, 44122, USA. .
Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Ritz J; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Collier AC; University of Washington, Seattle, WA, USA.
Hogg E; Social & Scientific Systems, A DLH Company, MD, Silver Spring, USA.
Gross R; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Godfrey C; NIAID, Bethesda, MD, USA.
Kumarasamy N; YR Gaitonde Center for AIDS Research and Education, Chennai, India.
Kanyama C; University of North Carolina Project-Malawi, Lilongwe, Malawi.
Mellors JW; University of Pittsburgh, Pittsburgh, PA, USA.
Wallis CL; Lancet Laboratories and BARC SA, Johannesburg, South Africa.
Hughes MD; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Pokaż więcej
Corporate Authors:
ACTG A5288 Study Team
Źródło:
AIDS research and therapy [AIDS Res Ther] 2023 Jan 05; Vol. 20 (1), pp. 3. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Humans ; Female ; Adult ; Male ; Reverse Transcriptase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/adverse effects ; Protease Inhibitors/therapeutic use ; Antiretroviral Therapy, Highly Active ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Viral Load ; RNA ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific.
Autorzy:
Rupasinghe D; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Kumarasamy N; CART CRS, Voluntary Health Services, Chennai, India.
Pujari S; Institute of Infectious Diseases, Pune, India.
Sun LP; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Merati TP; Faculty of Medicine Udayana University & Sanglah Hospital, Bali, Indonesia.
Lee MP; Queen Elizabeth Hospital, Hong Kong SAR, Hong Kong.
Kinh NV; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Do CD; Bach Mai Hospital, Hanoi, Vietnam.
Avihingsanon A; HIV-NAT/ Thai Red Cross AIDS Research Centre and Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Jiamsakul A; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Pokaż więcej
Corporate Authors:
IeDEA Asia-Pacific
Źródło:
HIV medicine [HIV Med] 2022 Oct; Vol. 23 (9), pp. 959-968. Date of Electronic Publication: 2022 Feb 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Adult ; Asia/epidemiology ; DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Hepatitis C Antibodies ; Humans ; Prevalence ; RNA
Czasopismo naukowe
Tytuł:
Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia.
Autorzy:
Teeraananchai S; Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand.; HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Law M; The Kirby Institute, UNSW, Sydney, New South Wales, Australia.
Boettiger D; The Kirby Institute, UNSW, Sydney, New South Wales, Australia.
Mata N; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Gupte N; BJ Government Medical College and Sassoon General Hospital, Pune, India.
Chan YL; Queen Elizabeth Hospital, Kowloon, Hong Kong SAR.
Pham TN; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Chaiwarith R; Chiang Mai University - Research Institute for Health Sciences, Chiang Mai, Thailand.; Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Ly PS; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Chan YJ; Taipei Veterans General Hospital, Taipei, Taiwan.
Kiertiburanakul S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yunihastuti E; Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
Pujari S; Institute of Infectious Diseases, Pune, India.
Azwa I; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Somia IKA; Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Ng OT; Tan Tock Seng Hospital, Singapore.
Do CD; Bach Mai Hospital, Hanoi, Vietnam.
Gani Y; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Jiamsakul A; The Kirby Institute, UNSW, Sydney, New South Wales, Australia.
Pokaż więcej
Corporate Authors:
TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific; Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand.
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2022 Aug; Vol. 25 (8), pp. e25989.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-HIV Agents*
HIV Infections*
Adolescent ; Adult ; Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count ; Female ; Humans ; Male ; Middle Aged ; Treatment Failure ; Viral Load
Czasopismo naukowe
Tytuł:
The ethics of exclusion: why pregnant and lactating women must be front and centre of HIV research.
Autorzy:
Singh JA; Howard College School of Law, University of KwaZulu-Natal, Durban, South Africa.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Moodley D; Department of Obstetrics and Gynaecology, School of Clinical Medicine, and Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
Little M; Kennedy Institute for Ethics and Department of Philosophy, Georgetown University, Washington, DC, USA.
Luna F; CONICET (National Scientific and Technological Research Council), FLACSO, Buenos Aires, Argentina.
Littler K; Global Health Ethics & Governance Unit, Research for Health Department, World Health Organization, Geneva, Switzerland.
Kumarasamy N; VHS Infectious Diseases Medical Centre, Voluntary Health Services, Chennai, India.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2022 Jul; Vol. 25 Suppl 2, pp. e25926.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Pregnancy Complications, Infectious*/epidemiology
Pregnancy Complications, Infectious*/prevention & control
Breast Feeding ; Female ; Humans ; Lactation ; Pregnancy ; Pregnant Women
Czasopismo naukowe
Tytuł:
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.
Autorzy:
Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre and Centre of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Hughes MD; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Salata R; Case Western Reserve University, Cleveland, Ohio, USA.
Godfrey C; Division of AIDS, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
McCarthy C; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Mugyenyi P; Joint Clinical Research Center, Kampala, Uganda.
Hogg E; Social & Scientific Systems, Inc., a DLH Holdings Company, Silver Spring, Maryland, USA.
Gross R; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Bukuru A; Joint Clinical Research Center, Kampala, Uganda.
Makanga M; Kenya Medical Research Institute/Center of Disease Control, Kisumu, Kenya.
Badal-Aesen S; Clinical HIV Research Unit, Helen Joseph Hospital, University of Witwatersrand, Johannesburg, South Africa.
Mave V; BJ Medical College Clinical Research Site, Pune, India.
Ndege BW; Moi University Clinical Research Center (MUCRC) CRS, Eldoret, Kenya.
Fontain SN; Les Centres GHESKIO Clinical Research Site, Port-au-Prince, Haiti.
Samaneka W; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
Secours R; Les Centres GHESKIO Clinical Research Site, Port-au-Prince, Haiti.
Van Schalkwyk M; Family Centre for Research with Ubuntu (FAMCRU), Stellenbosch University, Cape Town, South Africa.
Mngqibisa R; Durban International Clinical Research Site, King Edward Hospital, Enhancing Care Foundation, Durban, South Africa.
Mohapi L; Soweto AIDS Clinical Trials Group, Clinical Research Site, Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Valencia J; Barranco Clinical Research Site, Lima, Peru.
Sugandhavesa P; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Montalban E; San Miguel Clinical Research Site, Lima, Peru.
Munyanga C; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
Chagomerana M; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
Santos BR; Hospital Nossa Senhora da Conceicao CRS, Porto Alegre, Brazil.
Kumarasamy N; CART, Clinical Research Site, VHS Infection Disease Medical Centre, Chennai, India.
Kanyama C; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
Schooley RT; Division of Infectious Diseases, University of California, San Diego, California, USA.
Mellors JW; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Wallis CL; BARC-South Africa and Lancet Laboratories, Johannesburg, South Africa.
Collier AC; University of Washington School of Medicine, University of Washington, Seattle, Washington, USA.
Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Pokaż więcej
Corporate Authors:
A5288 Study team
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2022 Jun; Vol. 25 (6), pp. e25905.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Protease Inhibitors*/therapeutic use
HIV-1*/genetics
Anti-Retroviral Agents/therapeutic use ; Darunavir/therapeutic use ; Female ; Humans ; Male ; Nitriles ; Pyrimidines ; RNA/therapeutic use ; Raltegravir Potassium/adverse effects ; Ritonavir/therapeutic use ; Viral Load
Czasopismo naukowe
Tytuł:
Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India.
Autorzy:
Kausalya B; YRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Saravanan S; YRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Pallikkuth S; University of Miami Miller School of Medicine, 1580 NW 10th Avenue; BCRI 712, Miami, FL, 33136, USA.
Pahwa R; University of Miami Miller School of Medicine, 1580 NW 10th Avenue; BCRI 712, Miami, FL, 33136, USA.
Saini SR; University of Miami Miller School of Medicine, 1580 NW 10th Avenue; BCRI 712, Miami, FL, 33136, USA.
Iqbal S; YRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Solomon S; YRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Murugavel KG; YRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Poongulali S; YRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Kumarasamy N; YRG Centre for AIDS Research and Education (YRG CARE), Chennai, India.; Johns Hopkins University School of Medicine, Baltimore, MD, USA.; VHS-Infectious Diseases Medical Centre, Chennai, India.
Pahwa S; University of Miami Miller School of Medicine, 1580 NW 10th Avenue; BCRI 712, Miami, FL, 33136, USA. .
Pokaż więcej
Źródło:
BMC immunology [BMC Immunol] 2022 May 17; Vol. 23 (1), pp. 24. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Cardiovascular Diseases*/epidemiology
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Biomarkers ; Disease Progression ; Humans ; India/epidemiology ; Inflammation ; Morbidity
Czasopismo naukowe
Tytuł:
Patterns and prognosis of holding regimens for people living with HIV in Asian countries.
Autorzy:
Kim JH; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Jiamsakul A; The Kirby Institute, UNSW Sydney, Sydney, Australia.
Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Huy BV; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
Ng OT; Tan Tock Seng Hospital, Singapore, Singapore.
Ly PS; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Lee MP; Queen Elizabeth Hospital, Kowloon, Hong Kong SAR.
Chan YJ; Taipei Veterans General Hospital, Taipei, Taiwan.
Gani YM; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
Azwa I; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Avihingsanon A; HIV-NAT/ Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Merati TP; Faculty of Medicine Udayana University & Sanglah Hospital, Denpasar, Bali, Indonesia.
Pujari S; Institute of Infectious Diseases, Pune, India.
Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
Do CD; Bach Mai Hospital, Hanoi, Vietnam.
Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Yunihastuti E; Faculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Ross J; TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand.
Choi JY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Pokaż więcej
Corporate Authors:
IeDEA Asia-Pacific
Źródło:
PloS one [PLoS One] 2022 Mar 30; Vol. 17 (3), pp. e0264157. Date of Electronic Publication: 2022 Mar 30 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents*/pharmacology
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Adult ; Female ; Humans ; Lamivudine/therapeutic use ; Male ; Middle Aged ; Prognosis ; Reverse Transcriptase Inhibitors/therapeutic use ; Viral Load ; Zidovudine/therapeutic use
Czasopismo naukowe
Tytuł:
Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV.
Autorzy:
Han WM; The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.; HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Law MG; The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS Infectious Diseases Medical Centre, VHS, Chennai, India.
Chaiwarith R; Chiang Mai University - Research Institute for Health Sciences, Chiang Mai, Thailand.
Ly PS; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Merati TP; Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
Do CD; Bach Mai Hospital, Hanoi, Vietnam.
Yunihastuti E; Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Azwa I; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Lee MP; Queen Elizabeth Hospital, Hong Kong SAR, China.
Pham TN; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Chan YJ; Taipei Veterans General Hospital, Taipei, Taiwan.
Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Ng OT; Tan Tock Seng Hospital, National Centre for Infectious Diseases, Singapore.
Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
Pujari S; Institute of Infectious Diseases, Pune, India.
Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Gani Y; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
Mave V; BJ Government Medical College- Johns Hopkins University Clinical Research Site, Pune, India.
Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Corporate Authors:
TREAT Asia HIV Observational Database of IeDEA Asia-Pacific
Źródło:
HIV medicine [HIV Med] 2022 Mar; Vol. 23 (3), pp. 274-286. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
Metabolic Syndrome*/complications
Metabolic Syndrome*/drug therapy
Metabolic Syndrome*/epidemiology
Adult ; CD4 Lymphocyte Count ; Cohort Studies ; Humans ; Male ; Reverse Transcriptase Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
HIV treatment outcomes among people who acquired HIV via injecting drug use in the Asia-Pacific region: a longitudinal cohort study.
Autorzy:
Han WM; Kirby Institute, UNSW, Sydney, Australia.; HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Jiamsakul A; Kirby Institute, UNSW, Sydney, Australia.
Salleh NAM; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Centre of Excellence for Research in AIDS (CERiA), University of Malaya, Kuala Lumpur, Malaysia.
Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Huy BV; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Yunihastuti E; Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Do CD; Bach Mai Hospital, Hanoi, Vietnam.
Merati TP; Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
Gani YM; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Chan YJ; Taipei Veterans General Hospital, Taipei, Taiwan.
Lee MP; Queen Elizabeth Hospital, Hong Kong, China.
Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
Ng OT; Tan Tock Seng Hospital, Tan Tock Seng, Singapore.
Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
Sangle S; BJ Government Medical College and Sassoon General Hospital, Pune, India.
Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Corporate Authors:
TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific Group
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2021 May; Vol. 24 (5), pp. e25736.
Typ publikacji:
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Pharmaceutical Preparations*
Adult ; Asia/epidemiology ; CD4 Lymphocyte Count ; Cohort Studies ; Female ; Humans ; Longitudinal Studies ; Male ; Treatment Outcome ; Viral Load
Czasopismo naukowe
Tytuł:
Economic vulnerability and non-initiation of antiretroviral therapy in India: a qualitative study.
Autorzy:
Colocci I; Harvard University, Cambridge, USA.
Perlo J; Harvard University, Cambridge, USA.
Rajagopal SS; Harvard University, Cambridge, USA.
Betancourt TS; School of Social Work and Research Program on Children and Adversity, Boston College, Boston, USA.
Pradeep A; Y.R. Gaitonde Centre for AIDS Research and Education, Chennai, India.
Mayer KH; Fenway Health, Boston, USA.; Harvard Medical School, Boston, USA.
Kumarasamy N; Y.R. Gaitonde Centre for AIDS Research and Education, Chennai, India.
O'Cleirigh C; Behavioral Medicine and Chester M. Pierce, MD Division of Global Psychiatry, Massachusetts General Hospital, Boston, USA.
Katz IT; Harvard Medical School, Boston, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, USA.; MGH Global Health, Massachusetts General Hospital, Boston, USA.; Harvard Global Health Institute, Cambridge, USA.
Chan BT; Harvard Medical School, Boston, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Pokaż więcej
Źródło:
AIDS care [AIDS Care] 2021 Apr; Vol. 33 (4), pp. 423-427. Date of Electronic Publication: 2020 Jan 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-HIV Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*economics
HIV Infections/*drug therapy
Adult ; CD4 Lymphocyte Count ; Female ; HIV Infections/psychology ; Humans ; India ; Interviews as Topic ; Male ; Poverty ; Private Sector ; Qualitative Research
Czasopismo naukowe
Tytuł:
Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study.
Autorzy:
Sudjaritruk T; Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Teeraananchai S; The HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand.
Kariminia A; The Kirby Institute, UNSW Australia, Sydney, Australia.
Lapphra K; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site, VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
Fong MS; Hospital Likas, Kota Kinabalu, Malaysia.
Hansudewechakul R; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Bunupuradah T; The HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Ly PS; National Centre for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia.
Nallusamy RA; Penang Hospital, Penang, Malaysia.
Sohn AH; TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Sirisanthana V; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Pokaż więcej
Corporate Authors:
TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2020 Jul; Vol. 23 (7), pp. e25550.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Viral Load*
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*virology
Adolescent ; Cambodia ; Child ; Cohort Studies ; Drug Therapy, Combination ; Female ; HIV-1 ; Humans ; Malaysia ; Male ; Proportional Hazards Models ; Retrospective Studies ; Reverse Transcriptase Inhibitors/therapeutic use ; Viremia/drug therapy ; Viremia/virology
Czasopismo naukowe
Tytuł:
Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium.
Autorzy:
Jesson J; Inserm U1027, Université Paul Sabatier Toulouse 3, Toulouse, France. julie_.; Inserm, UMR 1027 - Epidémiologie et analyses en santé publique: risques, maladies chroniques et handicaps - Université Paul Sabatier Toulouse 3, Equipe 2: Axe santé de l'enfant et de l'adolescent en Afrique, 37 Allées Jules Guesde, 31073 Toulouse Cedex 7, France, Toulouse Cedex 7, France. julie_.
Desmonde S; Inserm U1027, Université Paul Sabatier Toulouse 3, Toulouse, France.
Yiannoutsos CT; Indiana University, Fairbanks School of Public Health, Indianapolis, IN, USA.
Patten G; School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Malateste K; Inserm U1219, Bordeaux, France.; Bordeaux Population Health Center, Université de Bordeaux, Bordeaux, France.
Duda SN; Vanderbilt University Medical Center, Nashville, TN, USA.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
Yotebieng M; Division of Epidemiology, The Ohio State University, College of Public Health, Columbus, OH, USA.
Davies MA; School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Musick B; Indiana University School of Medicine, Indianapolis, IN, USA.
Leroy V; Inserm U1027, Université Paul Sabatier Toulouse 3, Toulouse, France.
Ciaranello A; The Medical Practice Evaluation Center, Boston, MA, USA.; The Division of General Internal Medicine, Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA.
Pokaż więcej
Corporate Authors:
IeDEA
Źródło:
BMC research notes [BMC Res Notes] 2020 May 24; Vol. 13 (1), pp. 249. Date of Electronic Publication: 2020 May 24.
Typ publikacji:
Journal Article
MeSH Terms:
Acquired Immunodeficiency Syndrome/*drug therapy
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Acquired Immunodeficiency Syndrome/epidemiology ; Adolescent ; Africa, Central ; Africa, Eastern ; Africa, Southern ; Age Distribution ; Asia, Southeastern ; Caribbean Region ; Central America ; Child ; Child, Preschool ; Cohort Studies ; Databases, Factual ; Female ; HIV Infections/epidemiology ; Humans ; Infant ; Male ; South America ; World Health Organization
Czasopismo naukowe
Tytuł:
Feasibility and acceptability of a psychosocial and adherence electronic patient reported outcomes (PROs) system at an HIV care center in southern India.
Autorzy:
Sinha N; Harvard University, Cambridge, MA, USA.
Yang A; Harvard University, Cambridge, MA, USA.
Pradeep A; Y.R. Gaitonde Centre for AIDS Research and Education, Chennai, India.
Bhuvaneswari R; Chennai Antiviral Research and Treatment (CART) Clinical Research Site, Chennai, India.
Kumarasamy N; Chennai Antiviral Research and Treatment (CART) Clinical Research Site, Chennai, India.
O'Cleirigh C; Fenway Health, Boston, MA, USA.; Behavioral Medicine and Chester M. Pierce, MD Division of Global Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Mayer KH; Fenway Health, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Chan BT; Harvard Medical School, Boston, MA, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Pokaż więcej
Źródło:
AIDS care [AIDS Care] 2020 May; Vol. 32 (5), pp. 630-636. Date of Electronic Publication: 2019 Sep 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*administration & dosage
Data Collection/*methods
HIV Infections/*drug therapy
Medication Adherence/*statistics & numerical data
Patient Acceptance of Health Care/*statistics & numerical data
Adult ; Feasibility Studies ; Female ; HIV Infections/epidemiology ; Humans ; India/epidemiology ; Interviews as Topic ; Middle Aged ; Patient Reported Outcome Measures ; Risk-Taking ; Substance-Related Disorders/epidemiology ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
Autorzy:
Lee DJ; Harvard Medical School, Boston, Massachusetts, United States of America.; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site, Voluntary Health Services, Chennai, India.
Resch SC; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Sivaramakrishnan GN; National Institute for Research in Tuberculosis, Chennai, India.
Mayer KH; Harvard Medical School, Boston, Massachusetts, United States of America.; The Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Tripathy S; National Institute for Research in Tuberculosis, Chennai, India.
Paltiel AD; Yale School of Public Health, New Haven, Connecticut, United States of America.
Freedberg KA; Harvard Medical School, Boston, Massachusetts, United States of America.; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Reddy KP; Harvard Medical School, Boston, Massachusetts, United States of America.; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jul 02; Vol. 14 (7), pp. e0218890. Date of Electronic Publication: 2019 Jul 02 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Cost-Benefit Analysis*
Drug Resistance, Bacterial*
HIV Infections/*diagnosis
Tuberculosis/*diagnosis
Adult ; Female ; HIV Infections/microbiology ; HIV Infections/virology ; Health Care Costs ; Humans ; India/epidemiology ; Male ; Microscopy ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/pathogenicity ; Point-of-Care Systems ; Public Sector ; Rifampin/adverse effects ; Rifampin/therapeutic use ; Sputum/microbiology ; Tuberculosis/drug therapy ; Tuberculosis/economics ; Tuberculosis/microbiology
Czasopismo naukowe
Tytuł:
Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.
Autorzy:
Ku SW; Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Division of Infectious Diseases, Department of Medicine, Taipei City Hospital Renai Branch, Taipei, Taiwan.
Jiamsakul A; The Kirby Institute, UNSW Sydney, NSW, Australia.
Joshi K; Institute of Infectious Diseases, Pune, India.
Pasayan MKU; Research Institute for Tropical Medicine, Manila, Philippines.
Widhani A; Working Group on AIDS, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Chaiwarith R; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Avihingsanon A; Faculty of Medicine, Chulalongkorn University and HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Ly PS; National Center for HIV/AIDS, Dermatology & STDs, and University of Health Sciences, Phnom Penh, Cambodia.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), YRGCARE Medical Centre, VHS, Chennai, India.
Do CD; Bach Mai Hospital, Hanoi, Vietnam.
Merati TP; Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
Nguyen KV; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Kamarulzaman A; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Lee MP; Queen Elizabeth Hospital, Hong Kong SAR, China.
Choi JY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Sim BLH; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
Ng OT; Tan Tock Seng Hospital, Tan Tock Seng, Singapore.
Ratanasuwan W; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Wong WW; Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Pokaż więcej
Corporate Authors:
TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2019 Mar; Vol. 22 (3), pp. e25264.
Typ publikacji:
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*complications
Trimethoprim, Sulfamethoxazole Drug Combination/*therapeutic use
Tuberculosis/*prevention & control
Adult ; Anti-HIV Agents/therapeutic use ; Anti-Retroviral Agents/therapeutic use ; Asia/epidemiology ; Cohort Studies ; Female ; HIV Infections/drug therapy ; Humans ; Male ; Middle Aged ; Tuberculosis/epidemiology ; Tuberculosis/etiology ; Tuberculosis/mortality ; Viral Load
Czasopismo naukowe
Tytuł:
The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV.
Autorzy:
Ahn MY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea.; Department of Internal Medicine, Seoul Medical Center, Seoul, South Korea.
Jiamsakul A; The Kirby Institute, UNSW, Sydney, NSW, Australia.
Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Khol V; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Pham TT; Bach Mai Hospital, Hanoi, Vietnam.
Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
Avihingsanon A; HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), YRGCARE Medical Centre, VHS, Chennai, India.
Wong WW; Taipei Veterans General Hospital, Taipei, Taiwan.
Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pujari S; Institute of Infectious Diseases, Pune, India.
Nguyen KV; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Lee MP; Queen Elizabeth Hospital, Hong Kong SAR, China.
Kamarulzaman A; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Merati TP; Faculty of Medicine Udayana University & Sanglah Hospital, Bali, Indonesia.
Yunihastuti E; Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Ng OT; Tan Tock Seng Hospital, Singapore City, Singapore.
Sim BLH; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
Ratanasuwan W; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Choi JY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Pokaż więcej
Corporate Authors:
IeDEA Asia-Pacific
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2019 Feb; Vol. 22 (2), pp. e25228.
Typ publikacji:
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Adult ; Age Factors ; Aged ; Anti-Retroviral Agents/therapeutic use ; Asia/epidemiology ; CD4 Lymphocyte Count ; Comorbidity ; Databases, Factual ; Female ; HIV Infections/epidemiology ; HIV Infections/immunology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies